PPA
MLNT

Parametric Portfolio Associates’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Parametric Portfolio Associates’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-21,410
Closed -$142K – 4044
2019
Q2 		$142K Buy
+21,410
New +$81.5K ﹤0.01% 3804
2018
Q4 		– Sell
-5,513
Closed -$109K – 4011
2018
Q3 		$109K Buy
5,513
+2,412
+78% +$61K ﹤0.01% 3838
2018
Q2 		$98K Buy
3,101
+1,091
+54% +$39.3K ﹤0.01% 3812
2018
Q1 		$74K Sell
2,010
-118
-6% -$7.76K ﹤0.01% 3881
2017
Q4 		$168K Buy
+2,128
New +$157K ﹤0.01% 3780

Other funds holding MLNT

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SC
Sculptor Capital New York $8.88B AUM 27.49% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $3.03B AUM 104.56% 1-Year Est. Return